Tested Applications
| Positive WB detected in | mouse skeletal muscle tissue |
| Positive IHC detected in | human skeletal muscle tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
24610-1-AP targets MBNL3 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag20113 Product name: Recombinant human MBNL3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 156-230 aa of BC042090 Sequence: SAASAMALQPGTLQLIPKRSALEKPNGATPVFNPTVFHCQQALTNLQLPQPAFIPAGPILCMAPASNIVPMMHGA Predict reactive species |
| Full Name | muscleblind-like 3 (Drosophila) |
| Calculated Molecular Weight | 354 aa, 39 kDa |
| Observed Molecular Weight | 38 kDa |
| GenBank Accession Number | BC042090 |
| Gene Symbol | MBNL3 |
| Gene ID (NCBI) | 55796 |
| RRID | AB_2879637 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NUK0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MBNL3, also named as Muscleblind-like protein 3 or Cys3His CCG1-required protein, is a 354 amino acid protein, which contains four C3H1-type zinc fingers and belongs to the muscleblind family. MBNL3 localizes in the nucleus and is highly expressed in the placenta. MBNL3 mediates pre-mRNA alternative splicing regulation and plays a role in myotonic dystrophy pathophysiology. MBNL3 could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for MBNL3 antibody 24610-1-AP | Download protocol |
| WB protocol for MBNL3 antibody 24610-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The MBNL3 Polyclonal antibody (catalog number 24610-1-AP) has a total of 2 citations. These appear in the journals Scientific Reports and Cell Cycle. The associated research fields include cancer biology, specifically cholangiocarcinoma tumor progression, metastasis, and prognostic biomarkers, as well as RNA biology involving TRIM71 and IMP1-mediated regulation of target RNAs. Both studies used human samples, with applications in IHC and WB.
| Species | Application | Title |
|---|---|---|
Sci Rep MBNL3 regulates tumor progression and metastasis in cholangiocarcinoma and serves as a prognostic biomarker. | ||
Cell Cycle TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs. |









